Gray 101

New to gray-market tirzepatide? Start here. We’ll work through sellers, batch testing, reconstitution and the numbers on a syringe—without expecting you to know the jargon already.

• Compare a vendor
• Check a COA
• Understand reconstitution
• Work out mg, mL and units

You can start from zero#

In these discussions, gray usually means research-labelled peptides sold outside the usual pharmacy route. Tirz is shorthand for tirzepatide; lyo means freeze-dried powder. A label is a claim about what is inside—not confirmation of it.

You don’t need a purchase to join the conversation. Bring a question, a redacted COA or a term you keep seeing. The Dictionary is there when you need it.

Setting expectations#

1. The vial price is only part of the cost. Count shipping, testing, supplies and the possibility of losing the payment or shipment.
2. A good delivery review is not a lab result. “It arrived” and “it contains the stated amount” are different claims.
3. A new batch needs new evidence. Last year’s COA does not describe this month’s vial.
4. You may have no pharmacy support or reliable instructions. That gap is real; community confidence does not fill it.
5. There is no deadline to join in. A countdown sale is a poor reason to skip a check.

Keep one private record: listing, seller contact, payment reference, batch number and complete reports. Share a separate copy with your personal details removed.

Finding a vendor#

Vendors#

Compare the offer before the reputation. A storefront, reseller and manufacturer can be different businesses.

• Product: exact peptide and claimed mg per vial.
• Quantity: number of vials; confirm what “kit” means in that listing.
• Batch: an identifier that connects the offer, supplied vials and report.
• Evidence: a complete, verifiable COA—not a cropped purity percentage.
• Terms: total price, dispatch location, replacement/refund policy and who handles a problem.

Missing answers are useful information. Save them alongside the positive reviews.

Group buys#

A GB (group buy) combines orders. Group testing shares a lab bill. Check which one you are joining: neither automatically includes the other.

Ask who holds the money, selects the sample and publishes the result, including a disappointing one. TGC does not collect group-buy payments or guarantee an organizer.

International vs domestic warehouses#

“Domestic” describes dispatch location; it does not establish where the peptide was made. Ask which warehouse will actually ship your order and whether the quoted terms apply there.

International shipments add border and customs uncertainty. “Stealth packaging” is seller language, not a guarantee of delivery or lawful import. Do not agree to false declarations.

When you’re ready to order#

Verify the contact through the seller’s established page, not an unsolicited DM. Lookalike usernames and substituted payment details are easy to miss. Recheck any last-minute change through the original contact channel.

Use a separate email and community username if you want to keep medical discussions away from your main identity. Keep access to that email for receipts and disputes; a disposable inbox can disappear when you need it.

Shipping#

Get the estimated dispatch window and the point at which the seller will investigate a delay in writing. Tracking can lag; a tracking number alone does not prove the correct contents were sent.

On arrival, photograph the sealed parcel, labels, vial count and any damage. Match them to your order before discarding packaging. Redact the shipping label before posting pictures.

Returns#

Do not assume ordinary retail returns apply. If the order is wrong or damaged, send the order reference, a short description and photos; request a written resolution. Keep the material set aside while the issue is unresolved.

A refund fixes the payment problem. It does not establish what was in the vial.

Testing and quality control#

Testing your order#

Start with three separate questions:

• Identity: is the named peptide present?
• Purity: what related components did the method detect?
• Content / mass: how many mg were measured in the sample?

99% purity does not mean “99% of the labelled mg,” and it does not mean sterile. Keep the full result with its sample ID, date and method. See a COA explained.

Check the chemical form before comparing prices. Ask what the reported mg refers to: peptide content or total material including water and counterions. A “base,” “sodium” or “acetate” label does not prove that two products are interchangeable. An unexplained form or mass basis is an unresolved identity/content question, not a minor naming detail.

The often-cited FDA warning about sodium and acetate names semaglutide, not tirzepatide. Do not transfer that claim to another molecule—or treat the absence of that specific warning as evidence of safety. FDA’s wording · Counterions explained.

Group testing#

Agree on the batch, sample selection, lab, scope and cost split before sending anything. Record who supplied each vial and how it reached the lab. One result represents the tested sample; it cannot promise that every vial matches.

3P vs. 2P vendor tests#

Community shorthand often calls a vendor-provided report 2P, and buyer-organized testing 3P. Ask who controlled the sample, its route to the lab and publication of the result.

Use the lab’s own report verification service to check a Janoshik report. A valid code confirms the report; it does not connect your vial to that sample. Two gaps remain:

• Cherry-picked samples: a seller can submit a specially selected vial that does not represent ordinary orders.
• Batch hopping: a genuine report can be reused to market later material from a different batch.

Buyer-controlled testing is more informative when the sample comes from an ordinary order, selection is outside the seller’s control, and the order/batch history is documented. Blinding the lab to the seller’s identity can reduce one source of bias; it does not repair a seller-selected sample. Share disappointing results as well as good ones, and repeat sampling across batches. Even independent sampling cannot certify every vial.

Does sterility matter?#

Yes. Chemical purity, sterility and endotoxins are separate questions. BAC water’s preservative does not sterilize contaminated powder.

Clear does not mean endotoxin-free. Endotoxins are toxins from certain bacteria, and they can remain after those bacteria are killed. If injected, they can cause fever and shaking chills; severe reactions can involve dangerously low blood pressure and shock. Why this matters.

A routine purity result does not check for endotoxins. Ask whether the lab has performed a separate endotoxin test, rather than reading “99% purity” as an answer to both questions.

Sudden fever or rigors after an injection need urgent medical assessment. Fainting, confusion or breathing difficulty needs emergency help. Bring the product and batch details; do not try another injection to “test” the vial. Testing scope.

What do I test?#

Ask whether the lab’s peptide package covers identity, purity and quantitative content. Add questions about endotoxins, microbiological contamination or residues when the material’s history leaves those unresolved. No single purity cutoff answers all of them.

Compare labs and services · Understand residual solvents.

Reconstitution#

What is reconstituting?#

Reconstitution means adding a suitable liquid to dry material to make a solution. The mg in the vial and the mL of solution are different quantities. Water changes concentration; it does not add peptide.

Avoid vigorous shaking. Gentle swirling and time are preferable to trying to force powder into solution. Shaking creates foam and air–liquid interfaces that can promote aggregation in some protein formulations. That does not establish that a brief shake instantly destroys tirzepatide or its “tertiary structure.”

Mixing behavior depends on the actual formulation, not just the peptide name. The checks below explain common errors; they cannot supply missing compatibility or stability data for an unknown vial. Research on agitation and protein aggregation.

Shelf life#

Keep three dates separate: unopened expiry, first puncture and mixing date. Record any known heat exposure or storage interruption.

“28 days” is not a universal shelf life for mixed peptides. BAC water and filtration do not establish a storage limit for the resulting mixture. Ask for formulation-specific stability information; a clear-looking vial is not a shelf-life test.

Pfizer Hospira BAC water#

BAC water is bacteriostatic water for injection. Pfizer/Hospira’s product contains benzyl alcohol as a preservative; it is not plain drinking water or saline. Check the exact product, seal and expiry, and confirm compatibility with the material.

Its label requires the drug’s dilution instructions and warns that some drugs may be incompatible. It does not certify gray-market powder. Product information.

Supply sources#

For supplies, use a traceable pharmacy or medical supplier and verify the labelled product. “Reconstitution water” in a marketplace title is not enough to establish its contents or intended use.

Prep checklist

• Vial and batch details — Check the peptide name, claimed mg and batch record.
• Compatible diluent — Check the product, seal and expiry. Use BAC water only when it is compatible with the material.
• New sterile syringe and transfer needle — Match the capacity and connection type to the planned transfer. Keep these separate from used injection equipment.
• Alcohol swabs and a clean work surface — Have both ready before opening supplies.
• Labels and a pen — Record the batch, concentration, mixing date and supported storage limit.
• Sharps container — Keep it within reach for immediate disposal.

If filtration is part of a validated process: add its specified filter and sterile receiving container. The filtering section explains what a filter can and cannot do.

Gloves do not turn a kitchen counter into a sterile workspace. Basic injection-safety practices.

Calculate concentration#

Concentration = total peptide mg / final solution mL

Read “/” as divided by.

30 mg / 3 mL = 10 mg/mL

Each 1 mL contains 10 mg. Half a mL contains 5 mg. The total remains 30 mg.

Final volume is not automatically the volume of water added. Dissolved powder and other ingredients can contribute displacement volume. Its size depends on the formulation; do not assume a fixed correction for every 30 mg vial. A nominal “3 mL vial” is a container size, not a calibrated measuring vessel.

The example assumes 30 mg of peptide in a known final volume of 3 mL. It does not say “add 3 mL to any powder.” If content or final volume is uncertain, so is the concentration. Continue to syringe units.

Reconstitution with filtering#

0.22 μm means 0.22 micrometers. It describes a nominal pore size, not a certificate that the final solution is safe to inject.

• Microbial retention depends on the filter and a validated process, including sterile handling and a sterile receiving container.
• An ordinary 0.22 μm syringe filter does not reliably remove dissolved endotoxin. BAC water does not neutralize it either.
• Filtration does not verify peptide identity, remove every dissolved impurity or rescue unknown material.

Do not filter a cloudy or suspicious vial simply to make it look acceptable. Set it aside and investigate the cause. FDA: limits of filtration and endotoxin control.

Step-by-step reconstitution#

Check these in order before treating a mixing recipe as usable:

1. Match the materials. Identify the vial, batch, compatible diluent, supported volume and storage conditions. A peptide name alone does not provide all five.
2. Write the calculation first. Record total peptide mg, final solution mL and mg/mL. Keep added liquid separate from final volume.
3. Prepare a clean working area. Wash hands, use new sterile equipment, disinfect vial septa and let the alcohol dry. Do not touch sterile connection surfaces.
4. Account for vial pressure. A vacuum can pull liquid in abruptly; positive pressure can resist transfer or force liquid back out. Do not force a resistant plunger or overfill a vial. Pressure equalization depends on the vial and transfer device. Use its specified aseptic method; an open needle left venting to room air is not a universal safe fix.
5. Handle gently. For a compatible preparation whose instructions allow it, introduce liquid slowly down the inner wall rather than blasting the powder. Allow time to dissolve and swirl gently; do not shake vigorously, add heat or alter pH to force dissolution.
6. Inspect and label. Check for unexpected particles, cloudiness or gel. Record batch, concentration, mixing date and supported storage limit. Keep a photo of the label.

Never re-enter a vial with a used injection syringe. CDC injection safety. Pressure-management devices have their own sterility and single-use requirements; a vented adapter is not a blanket recommendation for every vial. Manufacturer precautions.

Checking pH#

A pH strip measures acidity approximately; it does not test identity or sterility. Use a method and acceptable range supported for the formulation. Do not add acids or bases to chase a range posted for a different product.

How should it look?#

For a preparation expected to be clear, unexpected cloudiness, visible particles or gel-like material are reasons to stop. A clear solution can still contain problems you cannot see.

Compare dry and mixed-vial photographs. Keep appearance separate from proof of quality.

Dosing and injections#

Dosing schedule considerations#

The familiar 2.5 mg, then 5 mg, then 7.5 mg sequence comes from tirzepatide treatment schedules. For context, the US Zepbound label describes:

This is not a six-month race to 15 mg. It describes the labelled medicine, not approval of a research vial or a personal treatment plan. Dose selection needs a qualified healthcare professional; the conversion below only tells you the volume for an already-selected amount. Full prescribing information.

Dosage math#

Keep the three questions separate:

1. Concentration: how many mg are in 1 mL?
2. Volume: how many mL contain the selected amount?
3. Syringe marking: where is that volume on this device?

Worked example · 30 mg in a final volume of 3 mL

1. Concentration
30 mg / 3 mL = 10 mg/mL
Divide total peptide mass by final solution volume.

2. Volume for an illustrative 2.5 mg amount
2.5 mg / (10 mg/mL) = 0.25 mL
Divide the selected amount by concentration.

3. Marking on a U-100 syringe
0.25 mL × (100 units/mL) = 25 units
Multiply mL by 100 for a U-100 scale.

25 units is correct only for this concentration and a U-100 scale. It is not 25 mg and is not a setting for every injection pen. This example converts an amount; it does not select a treatment dose.

Before using any calculation, check the vial’s content, final volume and the actual syringe scale independently. Confusing mg, mL and units has caused serious overdoses. Documented dosing errors.

Syringes#

U-100 means 100 marked units per mL. Capacity tells you how much the barrel holds; the smallest graduation tells you what you can read.

For the 0.25 mL / 25-unit example, a 0.3 mL or 0.5 mL U-100 syringe with a clearly marked 25-unit position is easier to match to the calculation than a 2-unit scale. A 1 mL syringe is not inherently wrong; its actual graduations matter. Choose capacity and readable increments together. Needle length and gauge are separate choices, not a consequence of barrel size. Manufacturer size/scale guide.

Dead space is liquid left in the needle, hub or tip after the plunger is fully depressed. It can waste medication during transfers and injections; the amount depends on the syringe/needle design and handling, not simply whether the barrel is 1 mL. Low-dead-space equipment reduces residual volume. Do not draw extra “to compensate,” flush an injection needle or chase the remainder with air. Use the device’s intended technique. Device design and medication waste.

U-40 markings and pen clicks are different scales. Injection Pens 101 covers the separate device terminology.

SubQ injections#

SubQ means under the skin. Tirzepatide’s labelled route is subcutaneous, not intravenous. Site selection, rotation and device handling should follow training for the specific product and device. Use fresh sterile equipment and never share an injection pen. Lilly instructions.

Prefer to watch first?

Watch Lilly’s single-dose vial demonstration. Choose Zepbound Single-Dose Vial on the page; the video also has a transcript.

It shows a ready-made liquid medicine, not mixing lyo. The volume and device instructions belong to that product—keep your own concentration calculation separate.

Injection site reactions#

ISR means injection-site reaction. Record when it started, whether it is spreading and any other symptoms; a photo helps track change but cannot diagnose the cause.

Spreading redness, heat, worsening pain, pus or fever needs prompt medical assessment. Breathing difficulty or swelling of the face or tongue needs emergency help. Do not dismiss these as “just histamine.” NHS: cellulitis · NHS: anaphylaxis.

Health monitoring#

Keep a simple log: what you used, batch, date, amount, concentration, symptoms and other medicines. If you need care, tell the clinician exactly what you took—including that the source or contents may be uncertain. Bring the vial details. You need help, not a perfect explanation.

Get urgent help for severe or persistent abdominal pain, repeated vomiting with inability to keep fluids down, fainting or serious allergic symptoms. Do not wait for a group chat to agree.

Lab panel providers#

Some services let you request blood tests directly, but availability and ordering rules depend on location. Before paying, establish which question the test answers, who reviews it and how an urgent result is handled.

Blood sugar, kidney function and electrolytes may be relevant depending on your history and symptoms; there is no universal “gray panel.” Blood work measures your health, while a COA measures a submitted sample. Neither substitutes for the other.

Eating disorders and malnutrition risk#

Less appetite should not mean barely eating or drinking. Persistent weakness, dizziness, inability to meet basic intake or distress around food deserves help. Weight change alone cannot tell you whether you are well nourished.

It is okay to ask for support without defending how you arrived here. Recognizing malnutrition.

Other tips#

• Keep private details private: crop labels, prescription details, faces and addresses out of public photos. Doxxing is a risk worth taking seriously.
• Separate facts from sales: disclose affiliate links, free samples and involvement in a group buy when sharing a recommendation.
• Ask a question others can answer: “Here is the batch and report; which number is the mg per vial?” works better than “Is this vendor good?”
• Keep corrections visible: update the original thread when a report is revised or a problem is resolved.

You do not need to become an expert overnight. Start with the claim in front of you, keep the evidence, and ask the next clear question. Continue with Testing 101 or browse all guides.